These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8563072)

  • 1. Patient evaluation of a new injection pen for growth hormone treatment in children and adults.
    Sjöblom K; Albertsson-Wikland K; Bengtsson BA; Johannsson G; Thorén M; Degerblad M; Savage MO
    Acta Paediatr Suppl; 1995 Sep; 411():63-5. PubMed ID: 8563072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system.
    Stanhope R; Albanese A; Moyle L; Hamill G
    Arch Dis Child; 1992 Aug; 67(8):994-7. PubMed ID: 1520018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotropin 16 IU KabiVial is more convenient than conventional administration systems for children on growth hormone therapy.
    Danielson K; Neumeyer L; Ritzén M
    Acta Paediatr Scand Suppl; 1990; 370():208-11. PubMed ID: 2260453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle.
    Dörr HG; Zabransky S; Keller E; Otten BJ; Partsch CJ; Nyman L; Gillespie BK; Lester NR; Wilson AM; Hyrén C; van Kuijck MA; Schuld P; Schoenfeld SL
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):383-92. PubMed ID: 12705363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a pen injector system for growth hormone treatment.
    Gluckman PD; Cutfield WS
    Arch Dis Child; 1991 Jun; 66(6):686-8. PubMed ID: 2053787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient acceptance of Nordiject: a new drug delivery system for growth hormone.
    Jørgensen JT; Mortensen HB; Jørgensen JO
    DICP; 1991 Jun; 25(6):585-8. PubMed ID: 1877265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments.
    Pang SC
    Expert Rev Med Devices; 2005 Jan; 2(1):27-32. PubMed ID: 16293025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified growth hormone therapy--first clinical experience with the KabiPen.
    Albertsson-Wikland K
    Acta Paediatr Scand Suppl; 1988; 343():103-6. PubMed ID: 3057801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone administration by means of an injection pen.
    Jørgensen JO; Møller J; Jensen FS; Jørgensen JT; Christiansen JS
    Pharmacol Toxicol; 1989 Aug; 65(2):96-9. PubMed ID: 2813289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of growth hormone by disposable preloaded syringes.
    Danielson K; Neumeyer L; Ritzén M
    Acta Paediatr Scand Suppl; 1990; 366():143-6. PubMed ID: 2403003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone therapy with a new delivery system.
    Jørgensen JT; Susgaard S
    Indian J Pediatr; 1991; 58 Suppl 1():43-50. PubMed ID: 1824374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
    Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
    Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
    Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
    Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation.
    Pang S; Kaplan B; Karande V; Westphal LM; Scott R; Givens C; Sacks P;
    Reprod Biomed Online; 2003 Oct; 7(3):319-26. PubMed ID: 14653893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of concentration and injection volume on the bioavailability of subcutaneous growth hormone: comparison of administration by ordinary syringe and by injection pen.
    Blok GJ; van der Veen EA; Susgaard S; Larsen F
    Pharmacol Toxicol; 1991 May; 68(5):355-9. PubMed ID: 1946180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.
    Verrips GH; Hirasing RA; Fekkes M; Vogels T; Verloove-Vanhorick SP; Delemarre-Van de Waal HA
    Acta Paediatr; 1998 Feb; 87(2):154-8. PubMed ID: 9512200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
    Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
    Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.